Fusion protein and use for bioconverting molecules
US-2025320469-A1 · Oct 16, 2025 · US
US9765307B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9765307-B2 |
| Application number | US-201514601162-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 20, 2015 |
| Priority date | Jan 20, 2014 |
| Publication date | Sep 19, 2017 |
| Grant date | Sep 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention pertains to an isolated P450 enzyme comprising or consisting of an amino acid sequence at least 80% identical to SEQ ID NO: 1, wherein said sequence comprises a threonine at position corresponding to position 225 and/or an aspartic acid mutation at position corresponding to position 289. The invention also concerns an isolated nucleic acid comprising a sequence encoding said enzyme, a vector comprising said nucleic acid, and a host cell containing said nucleic acid or said vector. Methods for preparing said enzyme and methods for producing steroid hormone precursors using the enzyme or the host cells featured in the invention are also provided.
Opening claim text (preview).
The invention claimed is: 1. An isolated P450 enzyme comprising an amino acid sequence at least 97% identical to SEQ ID NO: 1, wherein said sequence comprises a threonine at a position corresponding to position 225 and/or an aspartic acid at a position corresponding to position 289. 2. The enzyme according to claim 1 comprising a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3. 3. The enzyme according to claim 1 consisting of the sequence SEQ ID NO: 1. 4. A method for producing a steroid hormone precursor, comprising the steps of: a) contacting the P450 enzyme of claim 1 with an isolated adrenodoxin (Adx) polypeptide, an isolated adrenodoxin reductase (AdR) polypeptide and a substrate selected from the group consisting of polycyclic and unsaturated mono alcohols having an aliphatic side chain such as cholesterol, a cholesterol analogue and a cholesterol derivative in conditions allowing the transformation of said substrate into a steroid hormone precursor, and b) recovering the steroid hormone precursor. 5. The method according to claim 4 , wherein the steroid hormone precursor is pregnenolone. 6. The enzyme according to claim 1 , wherein said amino acid sequence is at least 98% identical to SEQ ID NO: 1. 7. The enzyme according to claim 1 , wherein said amino acid sequence is at least 99% identical to SEQ ID NO: 1.
Preparation of steroids · CPC title
acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title
for yeasts · CPC title
Steroid 11-beta-monooxygenase (1.14.15.4) · CPC title
Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.